Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Rocket Pharmaceuticals (NasdaqGM:RCKT) with a ...

Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Outperform ...

BMO Capital upgraded Goeasy (EHMEF) to Outperform from Market Perform with a price target of C$200, down from C$207. Goeasy trades at trough ...

In a report released today, Kevin O’Halloran from BMO Capital maintained a Buy rating on Hochschild Mining (HOC – Research Report), with a ...

Stock market corrections of 10% hurt. But research shows that they often don't portend worse things ahead for stocks.

The revised estimates put Wall Street's average year-end target for the S&P 500 at 6,607, implying an advance of more than 17% from Friday's close of 5,638.94, according to a recent survey of Wall ...

Economists had expected the unemployment rate to climb back up to 6.7 per cent in February, according to consensus estimates ...

Cardinal Energy Ltd. (TSX: CJ) ("Cardinal" or the "Company") is pleased to announce that it has completed its previously ...

Stock analysts at BMO Capital Markets started coverage on shares of Dyne Therapeutics (NASDAQ:DYN – Get Free Report) in a report released on Wednesday, Marketbeat Ratings reports. The brokerage ...

Fintel reports that on March 10, 2025, BMO Capital upgraded their outlook for Samsara (NYSE:IOT) from Market Perform to Outperform. As of March 4, 2025, the average one-year price target for ...

GE Vernova (NYSE:GEV – Free Report) had its price objective lowered by BMO Capital Markets from $471.00 to $420.00 in a report released on Monday morning,Benzinga reports. The brokerage currently has ...

The Federal Reserve is still expected to cut interest rates this year — but not until the fall — as policymakers weigh the fallout from President Trump’s tariffs on trade ...